These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16825927)

  • 21. Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease.
    Fleisher M; Marsal J; Lee SD; Frado LE; Parian A; Korelitz BI; Feagan BG
    Dig Dis Sci; 2018 Apr; 63(4):825-833. PubMed ID: 29484571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management.
    Larsen S; Bendtzen K; Nielsen OH
    Ann Med; 2010 Mar; 42(2):97-114. PubMed ID: 20166813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extradigestive manifestations of IBD in pediatrics.
    Aloi M; Cucchiara S
    Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():23-32. PubMed ID: 19530508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CT and MRI of Rare Extraintestinal Manifestations of Inflammatory Bowel Disease in Children and Adolescents.
    Raymond SB; Gee MS; Anupindi SA; Shailam R; Kaplan JL; Nimkin K
    J Pediatr Gastroenterol Nutr; 2016 Jul; 63(1):e1-9. PubMed ID: 27050046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteoporosis and other extraintestinal symptoms and complications of inflammatory bowel diseases.
    Reinshagen M; von Tirpitz C
    Dig Dis; 2003; 21(2):138-45. PubMed ID: 14571111
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of extraintestinal manifestations and other complications of inflammatory bowel disease.
    Loftus EV
    Curr Gastroenterol Rep; 2004 Dec; 6(6):506-13. PubMed ID: 15527681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
    Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Extraintestinal manifestations in chronic inflammatory bowel diseases].
    Vavricka SR; Greuter T; Zeitz J
    Ther Umsch; 2019 Jan; 75(5):281-285. PubMed ID: 30700241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease.
    Trikudanathan G; Venkatesh PG; Navaneethan U
    Drugs; 2012 Dec; 72(18):2333-49. PubMed ID: 23181971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extraintestinal manifestations of inflammatory bowel disease: focus on the musculoskeletal, dermatologic, and ocular manifestations.
    Evans PE; Pardi DS
    MedGenMed; 2007 Mar; 9(1):55. PubMed ID: 17435655
    [No Abstract]   [Full Text] [Related]  

  • 31. [Extra-intestinal manifestations].
    Descos L
    Rev Prat; 1991 Feb; 41(5):415-8. PubMed ID: 2011689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beyond the Bowel: Extraintestinal Manifestations of Inflammatory Bowel Disease.
    Olpin JD; Sjoberg BP; Stilwill SE; Jensen LE; Rezvani M; Shaaban AM
    Radiographics; 2017; 37(4):1135-1160. PubMed ID: 28548906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Network Approaches to Uncover Pathogenesis and Therapeutic Targets of Inflammatory Bowel Diseases.
    Mikami Y; Kanai T
    Keio J Med; 2023 Jun; 72(2):29-43. PubMed ID: 36908132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy.
    Hedin CRH; Vavricka SR; Stagg AJ; Schoepfer A; Raine T; Puig L; Pleyer U; Navarini A; van der Meulen-de Jong AE; Maul J; Katsanos K; Kagramanova A; Greuter T; González-Lama Y; van Gaalen F; Ellul P; Burisch J; Bettenworth D; Becker MD; Bamias G; Rieder F
    J Crohns Colitis; 2019 Apr; 13(5):541-554. PubMed ID: 30445584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Possible role of mucosal lymphocyte homing in the pathogenesis of extraintestinal manifestations in inflammatory bowel diseases].
    Müzes G
    Orv Hetil; 2003 Jul; 144(29):1441-6. PubMed ID: 12939865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cutaneous manifestations in inflammatory bowel disease].
    Chavez-Álvarez S; Gómez-Flores M; Ocampo-Candiani J
    Gac Med Mex; 2016; 152(5):622-630. PubMed ID: 27792697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rheumatologic and extraintestinal manifestations of inflammatory bowel diseases.
    Colìa R; Corrado A; Cantatore FP
    Ann Med; 2016 Dec; 48(8):577-585. PubMed ID: 27310096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease.
    Barrie A; Regueiro M
    Inflamm Bowel Dis; 2007 Nov; 13(11):1424-9. PubMed ID: 17567879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of extraintestinal manifestations in inflammatory bowel disease.
    Lakatos PL; Lakatos L; Kiss LS; Peyrin-Biroulet L; Schoepfer A; Vavricka S
    Digestion; 2012; 86 Suppl 1():28-35. PubMed ID: 23051724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases.
    Guillo L; Abreu M; Panaccione R; Sandborn WJ; Azevedo VF; Gensler L; Moghaddam B; Ahuja V; Ali SA; Allez M; Ananthakrishnan AN; Bhattacharya A; Dubinsky M; Griffiths A; Hart A; Korelitz B; Kotze PG; Koutroubakis IE; Lakatos PL; Lindsay JO; Magro F; Mantzaris GJ; Ng SC; O'Morain C; Panés J; Parigi T; Ran Z; Rogler G; Rubin DT; Sachar DB; Siegmund B; Steinwurz F; Tysk C; Vavricka S; Verstraete SG; Brezin AP; Haemel AK; Dignass A; Sands BE; Danese S; Peyrin-Biroulet L
    Lancet Gastroenterol Hepatol; 2022 Mar; 7(3):254-261. PubMed ID: 35051383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.